142 related articles for article (PubMed ID: 8098403)
21. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa.
Dao B; Blum J; Thieba B; Raghavan S; Ouedraego M; Lankoande J; Winikoff B
BJOG; 2007 Nov; 114(11):1368-75. PubMed ID: 17803715
[TBL] [Abstract][Full Text] [Related]
22. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
[TBL] [Abstract][Full Text] [Related]
23. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
[TBL] [Abstract][Full Text] [Related]
24. Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana.
Taylor J; Diop A; Blum J; Dolo O; Winikoff B
Int J Gynaecol Obstet; 2011 Jan; 112(1):40-4. PubMed ID: 21122848
[TBL] [Abstract][Full Text] [Related]
25. Abortion failure after illegal use of misoprostol--a case report.
Rouzi AA
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):376-8. PubMed ID: 20863260
[TBL] [Abstract][Full Text] [Related]
26. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.
Peyron R; Aubény E; Targosz V; Silvestre L; Renault M; Elkik F; Leclerc P; Ulmann A; Baulieu EE
N Engl J Med; 1993 May; 328(21):1509-13. PubMed ID: 8479487
[TBL] [Abstract][Full Text] [Related]
27. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
[TBL] [Abstract][Full Text] [Related]
28. [The illegal market for gender-related drugs as portrayed in the Brazilian news media: the case of misoprostol and women].
Diniz D; Castro R
Cad Saude Publica; 2011 Jan; 27(1):94-102. PubMed ID: 21340108
[TBL] [Abstract][Full Text] [Related]
29. The "Abortion Pill" Misoprostol in Brazil: Women's Empowerment in a Conservative and Repressive Political Environment.
Löwy I; Dias Villela Corrêa MC
Am J Public Health; 2020 May; 110(5):677-684. PubMed ID: 32191521
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of methotrexate and misoprostol for early abortion.
Ozeren S; Corakçi A; Yücesoy I; Mercan R; Arslan A; Erhan G
Gynecol Obstet Invest; 1997; 44(2):112-4. PubMed ID: 9286724
[TBL] [Abstract][Full Text] [Related]
31. The biomedicalisation of illegal abortion: the double life of misoprostol in Brazil.
Zordo SD
Hist Cienc Saude Manguinhos; 2016; 23(1):19-36. PubMed ID: 27008072
[TBL] [Abstract][Full Text] [Related]
32. Two regimens of misoprostol for treatment of incomplete abortion.
Blanchard K; Taneepanichskul S; Kiriwat O; Sirimai K; Svirirojana N; Mavimbela N; Winikoff B
Obstet Gynecol; 2004 May; 103(5 Pt 1):860-5. PubMed ID: 15121557
[TBL] [Abstract][Full Text] [Related]
33. [Medical abortion using methotrexate and misoprostol. Efficacy and tolerability].
Iamakov K; Pekhlivanov B; Amaliev I
Akush Ginekol (Sofiia); 2005; 44(3):16-8. PubMed ID: 16028385
[TBL] [Abstract][Full Text] [Related]
34. Building Bridges: A Case for Community Health Worker Provision of Misoprostol-Only Abortion in the First Trimester.
Tebbets C; Santana D; Ros Silvestre J; Redwine D
J Womens Health (Larchmt); 2018 Mar; 27(3):311-316. PubMed ID: 29040004
[TBL] [Abstract][Full Text] [Related]
35. Complications with use of misoprostol for abortion in Madagascar: between ease of access and lack of information.
Pourette D; Mattern C; Ratovoson R; Raharimalala P
Contraception; 2018 Feb; 97(2):116-121. PubMed ID: 29242087
[TBL] [Abstract][Full Text] [Related]
36. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
38. [Cytotec and abortion: the police, the vendors and women].
Diniz D; Madeiro A
Cien Saude Colet; 2012 Jul; 17(7):1795-804. PubMed ID: 22872341
[TBL] [Abstract][Full Text] [Related]
39. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
Hou S; Zhang L; Chen Q; Fang A; Cheng L
Int J Gynaecol Obstet; 2010 Nov; 111(2):126-30. PubMed ID: 20705290
[TBL] [Abstract][Full Text] [Related]
40. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
